menu

Medical Program: How mCRC Tumor Sidedness Guides Treatment Decisions

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

How mCRC Tumor Sidedness Guides Treatment Decisions

Program Information
Recommended
How mCRC Tumor Sidedness Guides Treatment Decisions
RestartResume
The sidedness of mCRC tumors can offer essential clues about which treatment approach is best for your patients.
  • Sponsored by

  • Overview

    Join Dr. Richard Kim of Moffitt Cancer Center as he reveals how the sidedness of a mCRC tumor affects not only the prognosis, but also the biologic you use for each individual patient.

    Conversations on Colorectal Cancer is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 10/21/19

Get a Dose of ReachMD in Your Inbox
and Practice Smarter Medicine

Stay current with the best in medical education.